![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
X
20
Loba Biotech Gmbh Fischamend At, based in Austria, is a pharmaceutical company.
One of their significant offerings is Naphazoline nitrate, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2023-091 - Rev 00
This Chemical Type CEP, issued on June 14, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 147 associated with this CEP further emphasizes